February 24, 2020

February 21, 2020

Subscribe to Latest Legal News and Analysis

NIA Will Hold Webinar on Nanomedicine: Diagnostics and Therapeutics Advancing through Nanotechnology

On March 7, 2018, the Nanotechnology Industries Association (NIA) will hold a webinar on “Nanomedicine:  Diagnostics and therapeutics advancing through nanotechnology.”  The webinar will focus on the diagnostic and therapeutic applications of nanotechnology, with the agenda including:

  • Regulatory landscape in Europe and beyond for nanomaterials in healthcare applications; and

  • Industry developments within nanomedicine from NIA Members:

    • Endomag — A United Kingdom/U.S. small- or medium-sized enterprise (SME) with minimally-invasive surgical guidance platform using magnetism (magnetized nanoparticles) to improve tissue localization in surgical oncology; and

    • Senolytx — A Spanish/U.S. SME developing a nanoparticle-based theraorutic composed of a mesoporous silica scaffold, loaded with the cyctotoxic doxorubin.

The webinar is open to all interested applicants and presentations will be available to all attendees.  Registration is now open.

©2020 Bergeson & Campbell, P.C.

TRENDING LEGAL ANALYSIS


About this Author

Lynn Bergeson, Campbell PC, Toxic Substances Control Act Attorney, federal insecticide lawyer, industrial biotechnology legal counsel, Food Drug Administration law
Managing Partner

Lynn L. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. Her knowledge of and involvement in the policy process allows her to develop client-focused strategies whether...

202-557-3801
Carla Hutton, Bergeson Campbell PC, global regulatory attorney, public health activists lawyer, metals industry legal counsel, Toxic Substances Control Act law
Regulatory Analyst

Since 1996, Carla Hutton has monitored, researched, and written about regulatory and legislative issues that may potentially affect Bergeson & Campbell, P.C. (B&C®) clients. She is responsible for creating a number of monthly and quarterly regulatory updates for B&C's clients, as well as other documents, such as chemical-specific global assessments of regulatory developments and trends. She authors memoranda for B&C clients on regulatory and legislative developments, providing information that is focused, timely and applicable to client initiatives. These tasks have proven invaluable to many clients, keeping them aware and abreast of developing issues so that they can respond in kind and prepare for the future of their business.

Ms. Hutton brings a wealth of experience and judgment to her work in federal, state, and international chemical regulatory and legislative issues, including green chemistry, nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the Toxic Substances Control Act (TSCA), Proposition 65, and the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) program.

202-557-3809